Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
Index Number EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

CAS Number International Chemical Identification
605-001-00-5 200-001-8 50-00-0 formaldehyde …%

ATP Inserted / Updated: CLP00/ATP06 This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation.
CLP Classification (Table 3)
Classification Labelling Specific Concentration limits, M-Factors Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Acute Tox. 3 * H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 5 %
Eye Irrit. 2; H319: 5 % ≤ C < 25 %
Skin Sens. 1; H317: C ≥ 0,2 %
Skin Corr. 1B; H314: C ≥ 25 %
Note B
Note D
Acute Tox. 3 * H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 * H331 H331
Muta. 2 H341 H341
Carc. 1B H350 H350

Signal Words Pictograms
Danger
GHS08
Health hazard
GHS05
Corrosion
GHS06
Skull and crossbones
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance Seveso Categories
Yes Named
H2
Notified classification and labelling
General Information
EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

Name CAS Number
The CAS number associated with this substance in the EC Inventory and/or REACH-IT is reported here. In some cases, e.g. for differently hydrated forms of the same substance, alternative CAS numbers have been notified. In those cases, the additional CAS numbers are published in the column “additional notified information” below.
200-001-8 Formaldehyde 50-00-0

Notified classification and labelling according to CLP criteria
Classification Labelling Specific Concentration limits, M-Factors Notes Classification affected by Impurities / Additives

This check appears when a notifier has indicated that an impurity or an additive present in the substance impacts the notified classification. ECHA cannot reveal the identity of the impurity/additive or determine the exact impact it has on the classification.

Additional Notified Information

State/form: The notified state/form of the substance for all notifications classifying in this manner is reported under this link. Additional CAS number(s): Occasionally, a notification contains a different CAS number than the one reported under the general information section above. In those cases, all different notified CAS numbers associated with the aggregated classification are reported under this link. IUPAC name(s): Publicly available IUPAC names from all notifications classifying in this manner are reported under this link.

Number of Notifiers

This number indicates how many companies notified this classification. All members of a REACH registration joint submission and all participants in a group of manufacturers/importers who notified are counted. The grouping is done automatically with no manual verification.

Joint Entries

This check appears when a classification comes from a lead dossier of a REACH registration joint submission. When a member submits a classification separately under Article 11(3) of REACH (opt-out), this classification is displayed separately and not marked as a joint entry.

Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
IUPAC Names 200 yes View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 3 H330  
  H331
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 2 H330 H330 Dgr
IUPAC Names 200 yes View details
Skin Sens. 1A H317 H317 Dgr
IUPAC Names 200 yes View details
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
State/Form
IUPAC Names
1352 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 3 H331 H331
Carc. 2 H351 (Inhalation) H351 (by inhalation)
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Note B
Note D
State/Form
IUPAC Names
918 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301   GHS08
GHS05
GHS07
GHS06
Dgr
355 View details
  H301+H311+H331
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 3 H331  
Resp. Sens. 1 H334 H334
STOT SE 3 H335 (Lungs) H335
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
IUPAC Names
101 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
State/Form
IUPAC Names
85 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
State/Form
IUPAC Names
77 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ca. C < 25 %
Skin Irrit. 2; : 5 % ca. C < 25 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
State/Form
IUPAC Names
66 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 2 H330 H330
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301   GHS08
GHS05
Dgr
IUPAC Names 46 View details
  H301+H311+H331
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331  
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 EUH071
GHS08
GHS05
GHS06
Dgr
45 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
37 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 2 H330 H330
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
IUPAC Names
35 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ca. C < 25 %
Skin Sens. 1; : C ca. .2 %
Eye Irrit. 2; : 5 % ca. C < 25 %
STOT SE 3; : C ca. 5 %
Skin Corr. 1B; : C ca. 25 %
Note B
Note D
IUPAC Names 34 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
State/Form
IUPAC Names
29 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351 (Suspected of ca...)
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
State/Form
IUPAC Names
27 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351  
Acute Tox. 3 H301   GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
State/Form
27 View details
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 3 H331  
STOT SE 3 H335 (Respiratory sys...) H335
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C > 5 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Sens. 1; : C ≥ .2 %
Note B
Note D
State/Form
IUPAC Names
26 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
  H301 Dgr
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
24 View details
  H311
  H314
  H317
  H331
  H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
State/Form
IUPAC Names
19 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 2 H330 H330
Carc. 2 H351  
Acute Tox. 3 H301   GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : C ≥ 5 %
STOT SE 3; : C ≥ 5 %
Eye Irrit. 2; : C ≥ 5 %
Skin Sens. 1; : C ≥ .1 %
State/Form
IUPAC Names
18 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 2 H330 H330
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS07
GHS06
Dgr
15 View details
Acute Tox. 3 H311 H311
Skin Corr. 1A H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 2 H330 H330
STOT SE 3 H335 (RTI) H335
Muta. 2 H341 H341
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
IUPAC Names 12 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Note B
Note D
State/Form
IUPAC Names
11 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 2 H330 H330
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
7 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : C ≥ 5 %
Skin Irrit. 2; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Note B
Note D
State/Form
6 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : 25 % ≤ C < 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : .02 % ≤ C < 100 %
STOT SE 3; : 5 % ≤ C < 100 %
6 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301   GHS08
GHS05
GHS06
Dgr
Eye Dam. 1; : 25 % ≤ C < 100 %
Skin Sens. 1; : .2 % ≤ C < 100 %
Skin Corr. 1C; : 25 % ≤ C < 100 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
6 View details
  H301+H311
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 2 H330 H330
Muta. 2 H341 H341 (Suspected of ca...)
Carc. 1B H350 H350 (May cause cance...)
Not Classified               5  
Acute Tox. 3 H301   GHS09
GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
State/Form
5 View details
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331  
Muta. 2 H341 H341
Carc. 1B H350 H350
Aquatic Chronic 2 H411 H411
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
Note B
Note D
IUPAC Names 4 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
STOT SE 3 H335 (no data) (Inhalation)  
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
yes State/Form
IUPAC Names
4 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 (H301) GHS08
GHS05
GHS06
Dgr
Note B
Note D
IUPAC Names 4 View details
Acute Tox. 3 H311 H311 (H311)
Skin Corr. 1B H314 H314 (H314)
Skin Sens. 1 H317 H317 (H317)
Acute Tox. 3 H331 H331 (H331)
Carc. 2 H351 H351 (H351)
Acute Tox. 3 H301 H301 GHS05
GHS06
Dgr
4 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 2 H330 H330
STOT SE 3 H335 (Respiratory tra...) H335
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS07
GHS06
Dgr
IUPAC Names 3 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
  H301 GHS08
GHS05
GHS06
Dgr
3 View details
  H311
  H314
  H317
  H331
  H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : C ca. .2 %
Skin Corr. 1B; : C ca. 25 %
STOT SE 3; : C ca. 5 %
Eye Irrit. 2; : 5 % ca. C < 25 %
Skin Irrit. 2; : 5 % ca. C < 25 %
IUPAC Names 2 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1C; : 25 % ≤ C < 100 %
Skin Sens. 1; : .2 % ≤ C < 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : 5 % ≤ C < 100 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
Note B
Note D
2 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Irrit. 2 H319  
Acute Tox. 2 H330 H330
STOT SE 3 H335 (Not applicable) H335
Carc. 2 H351 H351 (Suspected of ca...)
Acute Tox. 3 H301   Dgr
IUPAC Names 2 View details
Acute Tox. 3 H311  
Skin Corr. 1B H314  
Skin Sens. 1 H317  
Acute Tox. 3 H331  
Carc. 2 H351  
Flam. Gas 1 H220 H220 GHS08
GHS05
GHS06
Dgr
1 View details
Press. Gas (Liq.) H280 H280
Acute Tox. 4 H302 H302
Acute Tox. 3 H311 H311
Skin Irrit. 2 H315 H315
Skin Sens. 1 H317 H317
Acute Tox. 2 H330 H330
Resp. Sens. 1 H334 H334
Muta. 2 H341 H341
Carc. 1A H350 H350
STOT SE 1 H370 (data lacking) H370
STOT RE 1 H372 (data lacking) H372
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 (Dermal and Inha...) H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Note B
Note D
yes State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
STOT SE 3 H335 (not specified) (Inhalation) H335
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
Note B
Note D
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
  H319
Acute Tox. 3 H331 H331
  H336
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : 25 % ≤ C < 100 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : .2 % ≤ C < 100 %
Skin Corr. 1C; : 25 % ≤ C < 100 %
STOT SE 3; : 5 % ≤ C < 100 %
Note B
Note D
1 View details
Acute Tox. 3 H311 H311
  H314
Skin Irrit. 2 H315  
Skin Sens. 1 H317 H317
Eye Irrit. 2 H319  
Acute Tox. 2 H330 H330
STOT SE 3 H335 (Not applicable) H335
Carc. 2 H351 H351 (Suspected of ca...)
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Note B
Note D
IUPAC Names 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 2 H330 H330
STOT SE 3 H335 (Respiratory tra...) H335
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : .2 % ≤ C ≤ 35 %
STOT SE 3; : 5 % ≤ C < 35 %
Skin Corr. 1B; : 25 % ≤ C < 35 %
State/Form
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1C H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314  
  H315
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
  H319
Acute Tox. 2 H330 H330
STOT SE 3 H335 (Respiratory tra...) H335
Carc. 2 H351  
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : C ≥ 5 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
STOT SE 3 H335 (organs) H335
Carc. 2 H351 H351
Skin Sens. 1 H317 H317 GHS08
GHS07
Wng
State/Form
1 View details
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS07
GHS06
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
  H335
Carc. 2 H351 (Inhalation) H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : C > .2 %
Skin Corr. 1B; : C > 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C > 5 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
State/Form
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Met. Corr. 1 H290 H290 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : 5 % ≤ C ≤ 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Dam. 1; : 25 % ≤ C ≤ 100 %
Skin Sens. 1; : .2 % ≤ C ≤ 100 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Note B
Note D
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H301 H301
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 3 H331 H331
STOT SE 3 H335 (lung) H335
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C ≤ 25 %
Eye Irrit. 2; : 5 % ≤ C ≤ 25 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
STOT SE 3; : 5 % ≤ C ≤ 100 %
Skin Sens. 1; : .2 % ≤ C ≤ 100 %
Note B
Note D
IUPAC Names 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Irrit. 2 H319 H319
Acute Tox. 3 H331 H331
STOT SE 3 H335 (Unknown) (Oral) H335
Carc. 2 H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1C H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318 H318
Acute Tox. 3 H331 H331
Resp. Sens. 1 H334 H334
Muta. 2 H341  
Carc. 1A H350 H350
STOT SE 1 H370 (Respiratory Sys...) H370
STOT RE 1 H372 (Respiratory Sys...) H372
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C ≤ 25 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Eye Irrit. 2; : 5 % ≤ C ≤ 25 %
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : C ≥ .1 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
State/Form
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
  H400 EUH206
EUH207
1 View details
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Irrit. 2; : 5 % ≤ C < 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Note B
Note C
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301   GHS08
GHS05
GHS06
Dgr
Skin Sens. 1; : .2 % < C < 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
Eye Dam. 1; : 25 % < C < 100 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1C; : 25 % < C < 100 %
Note B
Note D
1 View details
  H301+H311
Acute Tox. 3 H311  
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Eye Dam. 1 H318  
Acute Tox. 2 H330 H330
Muta. 2 H341 H341 (Suspected of ca...)
Carc. 1B H350 H350 (May cause cance...)
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
STOT SE 3; : 5 % ≤ C ≤ 100 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Skin Sens. 1; : .2 % ≤ C ≤ 100 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
IUPAC Names 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
  H351
Acute Tox. 3 H301 H301 GHS08
GHS07
Wng
Eye Irrit. 2; : 5 % ≤ C < 25 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
STOT SE 3; : C ≥ 5 %
Skin Corr. 1B; : C ≥ 25 %
Note B
Note D
State/Form
IUPAC Names
1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS06
Dgr
Skin Corr. 1B; : C ≥ 25 %
STOT SE 3; : C ≥ 5 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Sens. 1; : C ≥ .2 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
Note B
Note D
IUPAC Names 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1A H317 H317
Acute Tox. 3 H331 H331
Muta. 2 H341 H341
Carc. 1B H350 H350
Acute Tox. 3 H301 H301 GHS08
GHS05
GHS07
GHS06
Dgr
Skin Sens. 1; : C ≥ .2 %
Skin Irrit. 2; : 5 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 5 % ≤ C < 25 %
STOT SE 3; : C ≥ 5 %
IUPAC Names 1 View details
Acute Tox. 3 H311 H311
Skin Corr. 1B H314 H314
Skin Sens. 1 H317 H317
Acute Tox. 3 H331 H331
Carc. 2 H351 H351

Number of Aggregated Notifications: 66